LifeSteps Financial’s Biogen BIIB Stock Holding History

LifeSteps Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.29K	Buy	+43	New	+$8.23K	﹤0.01%	429

Other funds holding BIIB

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

LifeSteps Financial's BIIB Position: Q2 2026 in Review

LifeSteps Financial opened a new position in Biogen (BIIB) in Q2 2026: 43 shares worth $9.29K. The stake represents ﹤0.01% of the portfolio and ranks #429 among its holdings.

380 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

LifeSteps Financial held 43 shares of Biogen worth $9.29K as of Q2 2026.
Biogen was a new LifeSteps Financial position in Q2 2026.
Biogen made up ﹤0.01% of LifeSteps Financial's portfolio in Q2 2026, its #429 holding.
380 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.